Pilot Study of Traditional Chinese Medicine (Qing-Re-Liang-Xue Decoction) as Complementary Medicine for Psoriasis Vulgaris of Blood-heat Syndrome.
Sponsored by The First Affiliated Hospital of Zhejiang Chinese Medical University
About this trial
Last updated 4 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended a year ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- 18-65 years;
- Had a diagnosis of psoriasis vulgaris for ≥6 months;
- TCM syndrome evaluation belongs to blood-heat type patients: it is more common in the advanced stage of psoriasis. Symptoms: skin lesions develop faster, skin lesions are bright red, blood loss is obvious, scales are dry and thick, itching is severe; upset, and thirsty, dry stool; red-purple tongue, yellow fur, string or slippery or rapid pulse;
- Patients without serious primary diseases, such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system or mental illnesses;
- Those who are willing to cooperate and can persist in the treatment without interruption;
- During the treatment period, those who have not taken or used other psoriasis drugs externally.
Exclusion Criteria
- Patients with serious primary diseases, such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system or mental illnesses;
- History of immunosuppressant medication in the past three months;
- Those who use other drugs during treatment or stop treatment on their own and have incomplete observation data;
- Pregnancy or risk of pregnancy, and/or lactation;
- Aged ≤18 or ≥65 years old;
- Patients with other types of psoriasis, such as articular, pustular, and erythroderma.